VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

TPBG

Gene Name TPBG
Sequence Strain (Species/Organism) Homo sapiens
NCBI Gene ID 7162
NCBI Protein GI 262205665
Genbank Accession AJ012159
Protein Accession NP_001159864
Taxonomy ID 9606
Chromosome No 6
Gene Starting Position 82363205
Gene Ending Position 82367416
Gene Strand (Orientation) +
Protein Name transcript variant 1
Protein pI 6.83
Protein Weight 43252.68
Protein Length 420
DNA Sequence
>NC_000006.12:82363205-82367416 Homo sapiens chromosome 6, GRCh38.p12 Primary Assembly
CTTTCTCTCTCTCTCTCTCTTAAAGTTGGCGCGCTCTCTTCACAAGTTCCATCACTACCCAAGAAGTGAG
GGGGCGGGGGGGACAGGCGGGAAGGCATTAATTACACCTAAATCTGAAGTTTGCGGCCTCAAGTACCACT
TTGATGGGGAGAGCTTCTGAAGCTTCCATACAACCTGCCGTGCCTTTGCTGCTGCCGCAGTAGATTTTCA
GCTCATTTCTTTCTGCTGCTGCTTCGCGCTGCTCTGTCATGCCTAAATCTATCTCGTCACTGCCAAAGGT
GCCTGAATCAGGGTGAATTCCACGAGATTCACCAGCGGTTTTGCTCCAGTCCAAGGTAAATACAGTATGC
AAAATGAGGAACCACCCAAGGATGTCGGGGAGGGGGGAGAGAAAGGGATTCCCTCACCTTTTCCGGCACA
TTCCTCGTTAATTTCCACCAGGAGGAGGCGCGCAGCCCAGCTCCCCTAGTCTCTCTTCTTAAATCCCCCT
ACCTACGGCTGCCGAGGTTGGCCGCGCGTCGGGAATCTCCCCGACAGTCCTGGCCCTCCCCCGCCCCCCG
GGTTGGTTTTTCCCAGCTGCGGAGGTTGGGAGGTTGGGCCAGGGGCTGGGGTGCGAAGAGAGTCGGCGCC
CGCAACGCGGAGCCGGGAAGTCGTCGCTACTCTGGTGGAACTCAGAGTTGGTTCTGGAGGCGGCGGACGC
GGAGGTGAGCAGTGGGAGCCCGCGGCCTGGGAGAGACCCGGGAGGCGTCGTTGGGGCCCCTCCCCATCCT
CGGGTGGAGAGTAGGGTTGGTTCGGGTTGCCACTGTACCCCGAGTCCCACTGCTGCTTTGTTCCCAGACT
CTCCCCTCCTCTTTGGAGATGACTTGAACCCCTTTGAGATCCGAGGGGCTGGCGGGGCGCGGGCTGGGGG
GCGACAGTTGTAGCTCCACTTCCTGCTAATGCGAGAAGGTACAAAAAGAGATCAAAAAGTCCTGTAACCT
GAAACTTCCCTCGCATCCTAACCGGGACCTGGTGGAGAGGTCTGGGCGGGGGCGGAGACACCCGGAGGCC
GACCTTCCGCCGAGGCGGTGCAGGAAGGAACGGGAGAGGGAGAAGTTTGGTAGGGAAGGAATTGGGGATT
AAGCGGTAAGTTAGACGCGGGAGACGAGTCTCCTCGGGAAAGGCGGAGGGCGGGAGGCCGGTCGGGTTTA
TTTAGTGTGGGCCAGGGAAGAAGGAAGACTTTGCGGTCTGGGTGTCGGATGCGCGTCCCCCTCCGGAGTA
AAAGTGACCGGAGGGGTTGGGGAGGCGAGGCCGGGGCGGGCTTTTGGAAGGAGGTCTCTGGGACAGACTG
GAGACGACTAGACTCGAAAAGGCCGGTTTTTGCACTCCGGAAGCCGCGGCAGCCACCGCTGTTCACGCCT
CTCTCCTGCTTGTCCCAGGTCCCTCAGAGGATCCAGCGAGGGGCGCCAACAAGAGGCGAAGAGGTGGCAC
CAGGGCGGCGGCAGGAAGAGGAGCGGGAGCAGGAGCGCGGAGCGGAGCGTCCCGACCCGCCGTGCGTACT
TTCTGGAGGGAAGGGGCGGGGGAATCGGCCCCTGAGGGAAGCGCCCGGTGGCGAGGGGGTTAGCCAAGTT
CCGGCTGCGGCGCCACTCCCTCGGTTCCACGAGAGGAAAGTTTTTTTTTTCCAGACGCTTCCGCCGGCTC
GCGCCCTCCGGGCCCAGCCTCCCGAGCCTTCGGAGCGGGCGCCGTCCCAGCCCAGCTCCGGGGAAACGCG
AGCCGCGATGCCTGGGGGGTGCTCCCGGGGCCCCGCCGCCGGGGACGGGCGTCTGCGGCTGGCGCGACTA
GCGCTGGTACTCCTGGGCTGGGTCTCCTCGTCTTCTCCCACCTCCTCGGCATCCTCCTTCTCCTCCTCGG
CGCCGTTCCTGGCTTCCGCCGTGTCCGCCCAGCCCCCGCTGCCGGACCAGTGCCCCGCGCTGTGCGAGTG
CTCCGAGGCAGCGCGCACAGTCAAGTGCGTTAACCGCAATCTGACCGAGGTGCCCACGGACCTGCCCGCC
TACGTGCGCAACCTCTTCCTTACCGGCAACCAGCTGGCCGTGCTCCCTGCCGGCGCCTTCGCCCGCCGGC
CGCCGCTGGCGGAGCTGGCCGCGCTCAACCTCAGCGGCAGCCGCCTGGACGAGGTGCGCGCGGGCGCCTT
CGAGCATCTGCCCAGCCTGCGCCAGCTCGACCTCAGCCACAACCCACTGGCCGACCTCAGTCCCTTCGCT
TTCTCGGGCAGCAATGCCAGCGTCTCGGCCCCCAGTCCCCTTGTGGAACTGATCCTGAACCACATCGTGC
CCCCTGAAGATGAGCGGCAGAACCGGAGCTTCGAGGGCATGGTGGTGGCGGCCCTGCTGGCGGGCCGTGC
ACTGCAGGGGCTCCGCCGCTTGGAGCTGGCCAGCAACCACTTCCTTTACCTGCCGCGGGATGTGCTGGCC
CAACTGCCCAGCCTCAGGCACCTGGACTTAAGTAATAATTCGCTGGTGAGCCTGACCTACGTGTCCTTCC
GCAACCTGACACATCTAGAAAGCCTCCACCTGGAGGACAATGCCCTCAAGGTCCTTCACAATGGCACCCT
GGCTGAGTTGCAAGGTCTACCCCACATTAGGGTTTTCCTGGACAACAATCCCTGGGTCTGCGACTGCCAC
ATGGCAGACATGGTGACCTGGCTCAAGGAAACAGAGGTAGTGCAGGGCAAAGACCGGCTCACCTGTGCAT
ATCCGGAAAAAATGAGGAATCGGGTCCTCTTGGAACTCAACAGTGCTGACCTGGACTGTGACCCGATTCT
TCCCCCATCCCTGCAAACCTCTTATGTCTTCCTGGGTATTGTTTTAGCCCTGATAGGCGCTATTTTCCTC
CTGGTTTTGTATTTGAACCGCAAGGGGATAAAAAAGTGGATGCATAACATCAGAGATGCCTGCAGGGATC
ACATGGAAGGGTATCATTACAGATATGAAATCAATGCGGACCCCAGATTAACGAACCTCAGTTCTAACTC
GGATGTCTGAGAAATATTAGAGGACAGACCAAGGACAACTCTGCATGAGATGTAGACTTAAGCTTTATCC
CTACTAGGCTTGCTCCACTTTCATCCTCCACTATAGATACAACGGACTTTGACTAAAAGCAGTGAAGGGG
ATTTGCTTCCTTGTTATGTAAAGTTTCTCGGTGTGTTCTGTTAATGTAAGACGATGAACAGTTGTGTATA
GTGTTTTACCCTCTTCTTTTTCTTGGAACTCCTCAACACGTATGGAGGGATTTTTCAGGTTTCAGCATGA
ACATGGGCTTCTTGCTGTCTGTCTCTCTCTCAGTACAGTTCAAGGTGTAGCAAGTGTACCCACACAGATA
GCATTCAACAAAAGCTGCCTCAACTTTTTCGAGAAAAATACTTTATTCATAAATATCAGTTTTATTCTCA
TGTACCTAAGTTGTGGAGAAAATAATTGCATCCTATAAACTGCCTGCAGACGTTAGCAGGCTCTTCAAAA
TAACTCCATGGTGCACAGGAGCACCTGCATCCAAGAGCATGCTTACATTTTACTGTTCTGCATATTACAA
AAAATAACTTGCAACTTCATAACTTCTTTGACAAAGTAAATTACTTTTTTGATTGCAGTTTATATGAAAA
TGTACTGATTTTTTTTTAATAAACTGCATCGAGATCCAACCGACTGAATTGTTAAAAAAAAAAAAAATAA
AGATTCTTAAAAGAATTACAGTGTGTGCAAGTTTGCTTTGAAAAAAGGATGAAGGGCAGGAGTATTCAAT
GGTCTTGGTTCCGATGATAATTATTACTTAACATAGCTGAGAATCAAACTGTAGCAATGTCTAATATAAA
TAGACTTGGGAGATCGTTTTGAAATGGTGGATCCTTTTAGTATTTAAATGGAGAGTTTGAGTATTCATGT
GACTGTATGGTCCCAAAGTTAATGCTATTTATGAAACAGTTTTGTAAGAACATAATGAAGTTGGTAAAAG
CTAAGCGTTCTGCACAATAAACAGTTCCCAGTTTGGGGCTTTTTCAAGGCTAATGAAGTTATTGTTGGTC
TAGAAAAATAGTATTTACTTAATAAAACTCTGTTTGAAATTGTTCTGTGGATTTTTAGAGCAGAATTTGA
AACAAATGTAATGCAAATAAATATAAAGATAAAGTGTCTTAAAGACAATATTCTGAAATAAAAGATATAA
AATATAATTTAA

Protein Sequence
>NP_001159864.1 trophoblast glycoprotein precursor [Homo sapiens]
MPGGCSRGPAAGDGRLRLARLALVLLGWVSSSSPTSSASSFSSSAPFLASAVSAQPPLPDQCPALCECSE
AARTVKCVNRNLTEVPTDLPAYVRNLFLTGNQLAVLPAGAFARRPPLAELAALNLSGSRLDEVRAGAFEH
LPSLRQLDLSHNPLADLSPFAFSGSNASVSAPSPLVELILNHIVPPEDERQNRSFEGMVVAALLAGRALQ
GLRRLELASNHFLYLPRDVLAQLPSLRHLDLSNNSLVSLTYVSFRNLTHLESLHLEDNALKVLHNGTLAE
LQGLPHIRVFLDNNPWVCDCHMADMVTWLKETEVVQGKDRLTCAYPEKMRNRVLLELNSADLDCDPILPP
SLQTSYVFLGIVLALIGAIFLLVLYLNRKGIKKWMHNIRDACRDHMEGYHYRYEINADPRLTNLSSNSDV

Molecule Role Protective antigen
Molecule Role Annotation In a pre-clinical murine model, the recombinant virus expressing the tumor associated antigen 5T4 (TPBG) induces protection against challenge with CT26–h5T4 (a syngeneic tumor line expressing h5T4). Anti-tumor activity is long lived, with protection still evident 6 months after the final vaccination. In a therapeutic setting, injection of mice with TroVax results in a reduction in tumor burden of >90% (Harrop et al., 2006).
Related Vaccines(s) Recombinant Human Papillomavirus Nonavalent Vaccine , Recombinant Modified Vaccinia Ankara-5T4 Vaccine
References